- $394.95m
- -$58.86m
- $97.67m
Brief: Standard Biotools Upon Termination Of Deal, Co May Be Required To Pay Somalogic Fee Of $19.1 Million And/Or Reimburse Somalogic's Expenses Up To $2 Million
Brief: Standard Biotools And Somalogic To Combine In All-Stock Merger
Media: Standard BioTools and SomaLogic are said to near merger deal - Bloomberg News
Brief: SomaLogic Expands Agreement With Novo Nordisk To 2025
Brief: Somalogic Q2 revenue USD 16.597 million
Somalogic Inc reports results for the quarter ended in June - Earnings Summary
Somalogic Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Somalogic Partners With Dante Genomics
Brief: Somalogic Partners With Dante Genomics
Brief: SomaLogic Says On June 15, Entered Second Amendment To Collaboration Agreement With Illumina Cambridge, With Illumina Inc
Brief: Somalogic Collaborates With Citogen To Establish First Authorized Site In Spain
Brief: SomaLogic Announces Chief Financial Officer Transition
Brief: Somalogic Reports First Quarter 2023 Financial Results
Brief: Somalogic Q1 Revenue USD 20.4 Mln
U.S. STOCKS ON THE MOVE-Terns Pharma, Rivian, Intel, Micron
U.S. STOCKS ON THE MOVE-Nikola, Cintas, Seagate
SomaLogic down on weak revenue forecast
U.S. RESEARCH ROUNDUP- Enliven Therapeutics, Lululemon Athletica, Walgreens
Brief: SomaLogic Inc - Full Year 2023 Revenue Guidance Of $80 Million-$84 Million